# BioNexus Gene Lab Corp: Form DEF 14A, filed Feb 27, 2025

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: DEF 14A
- Filed: 2025-02-27
- Accepted by EDGAR: Feb 27, 2025, 22:20 ET
- Period: 2025-03-19
- Accession: 0001477932-25-001335
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001335/bglc_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001335/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793225001335/bglc_def14a.htm

Filed Feb 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001477932-25-001335. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.